homehome Home chatchat Notifications


A sea-snail's venom could rival opioids in pain relief capability

Its venom is so powerful it can kill pain! Whoa.

Alexandru Micu
February 22, 2017 @ 6:46 pm

share Share

University of Utah researchers have identified a compound that could offer an alternative to opioids. Sourced from the venom of a small marine snail Conus regius, it blocks pain by targeting a non-opioid pathway in the brain.

Image credits James St. John / Flickr.

Opioids are very good at blocking pain, making them invaluable for medical applications. But they’re also very good at being addictive, which is a big problem. The CDC reports that some 91 people die from opioid overdose every day in the US alone and they always come back for more.

An alternative to opioids

So an alternative painkiller, one that doesn’t rely on the same brain structures as opioids but has the same punch, is needed. An alternative that the Conus regius, a small cone snail native to the Caribbean Sea, is poised to offer — this predatory critter’s venom, used to paralyze and kill prey, shows promise as a powerful painkiller.

“Nature has evolved molecules that are extremely sophisticated and can have unexpected applications,” begins Baldomera Olivera, Ph.D., professor in biology at the University of Utah.

“We were interested in using venoms to understand different pathways in the nervous system.”

The paper describes a compound isolated from the snail’s venom, called RglA, which acts through a different pathway than that targeted by opioid drugs. Rat studies have shown that its analog RglA4 can block α9α10 nicotinic acetylcholine pain receptors, effectively shutting down this pain pathway. Not only that, but the effect lasts for a long time, even after the substance has been cleared from the rat’s system (which took about 4 hours.) This would suggest that RglA4 has effects that go beyond numbing the sensation of pain — such as a regenerative effect on the nervous system.

“We found that the compound was still working 72 hours after the injection, still preventing pain,” said J. Michael McIntosh, M.D., professor of psychiatry at the University of Utah Health Sciences.

“What is particularly exciting about these results is the aspect of prevention,” he added. “Once chronic pain has developed, it is difficult to treat. This compound offers a potential new pathway to prevent pain from developing in the first place and offer a new therapy to patients who have run out of options.”

Rodent trials

To check if the substance would work on humans, the team took RglA and created 20 analogs of the compound. In essence, they took the bit that fits into the receptors, and put together slightly different configurations of it to see which one worked best. The analog RgIA4 was the one who bound the strongest to the human receptors.

To see how effective it would be as a painkiller, the team administered RglA4 to rodents who had previously been treated with a chemotherapy drug that induces extreme cold sensitivity and touch hypersensitivity. The team also set up two control groups — one which group was treated but didn’t receive RglA4, and one who was genetically modified to lack α9α10 receptors.

“Interactions that are not normally painful, like sheets rubbing against the body or pants against the leg, becomes painful,” said McIntosh.

The rodents who received RglA4 and the genetically altered control group didn’t show any signs of pain, but the other control group did.

“RgIA4 works by an entirely new pathway, which opens the door for new opportunities to treat pain,” McIntosh added.

“We feel that drugs that work by this pathway may reduce burden of opioid use.”

The full paper “Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain” has been published online in the journal PNAS.

share Share

A Simple Heat Hack Could Revolutionize How We Produce Yogurt

In principle, the method could be deployed tomorrow, researchers say.

Scientists Create a ‘Smart Sponge’ That Knows When to Heal and When to Fight Inflammation

This hydrogel could help millions of people lead a better life.

The Race to the Bottom: Japan Is Set to Start Testing Deep-Sea Mining

There's a big hidden cost to this practice.

Japan Just Smashed the Internet Speed World Record and It's Much Faster Than You Think

Researchers transmitted 127,500 GB every second — over the distance from Chicago to Dallas.

Can You Tell Which Knot Is Strongest? Most People Fail This Surprisingly Tough Challenge

Knots are a test of physical intuition and most of us are failing hard.

Scientists Call for a Global Pause on Creating “Mirror Life” Before It’s Too Late: “The threat we’re talking about is unprecedented”

Creating synthetic lifeforms is almost here, and the consequences could be devastating.

For the First Time Ever We Can See Planets Starting to Form Around a Star

JWST and ALMA peered through a natural opening in the star’s surrounding cloud to catch the action up close.

Low testosterone isn't killing your libido. Sugar is

Small increases in blood sugar can affect sperm and sex, even without diabetes

There might be an anti-aging secret hiding in magic mushrooms

Psilocybin extends cell life, and preserves aging DNA structures.

Not Just Hunters: Wooden Tools Unearth the Sophisticated, Plant-Eating World of Early Humans

What if the Stone Age wasn't really about stone?